Menengai Medical Ltd 13192153 false 2022-03-01 2023-02-28 2023-02-28 The principal activity of the company is Specialist medical practice activities Digita Accounts Production Advanced 6.30.9574.0 true 13192153 2022-03-01 2023-02-28 13192153 2023-02-28 13192153 bus:Director1 1 2023-02-28 13192153 core:CurrentFinancialInstruments core:WithinOneYear 2023-02-28 13192153 bus:Micro-entities 2022-03-01 2023-02-28 13192153 bus:AuditExemptWithAccountantsReport 2022-03-01 2023-02-28 13192153 bus:FullAccounts 2022-03-01 2023-02-28 13192153 bus:SmallCompaniesRegimeForAccounts 2022-03-01 2023-02-28 13192153 bus:RegisteredOffice 2022-03-01 2023-02-28 13192153 bus:Director1 2022-03-01 2023-02-28 13192153 bus:Director1 1 2022-03-01 2023-02-28 13192153 bus:PrivateLimitedCompanyLtd 2022-03-01 2023-02-28 13192153 countries:EnglandWales 2022-03-01 2023-02-28 13192153 bus:Director1 1 2022-02-28 13192153 2021-02-10 2022-02-28 13192153 2022-02-28 13192153 bus:Director1 1 2022-02-28 13192153 core:CurrentFinancialInstruments core:WithinOneYear 2022-02-28 13192153 bus:Director1 1 2021-02-10 2022-02-28 13192153 bus:Director1 1 2021-02-09 iso4217:GBP xbrli:pure

Registration number: 13192153

Menengai Medical Ltd

Annual Report and Unaudited Financial Statements

for the Year Ended 28 February 2023

 

Menengai Medical Ltd

Contents

Balance Sheet

1

Notes to the Unaudited Financial Statements

2

 

Menengai Medical Ltd

(Registration number: 13192153)
Balance Sheet as at 28 February 2023

2023
£

2022
£

Fixed assets

1,142

674

Current assets

23,787

16,529

Prepayments and accrued income

8,602

-

Creditors: Amounts falling due within one year

(25,702)

(12,853)

Net current assets

6,687

3,676

Total assets less current liabilities

7,829

4,350

Accruals and deferred income

(4,152)

(3,000)

 

3,677

1,350

Capital and reserves

3,677

1,350

For the financial year ending 28 February 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 27 November 2023
 

A Harris
Director

   
     
 

Menengai Medical Ltd

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
5 Chapel Court
Chudleigh
Devon
TQ13 0FH
UK

These financial statements were authorised for issue by the director on 27 November 2023.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

The financial statements are prepared in sterling, which is the functional currency of the company, and rounded to the nearest £.

2

Staff numbers

The average number of persons employed by the company (including the director) during the year was 1 (2022 - 1).

3

Related party transactions

During the year a loan was made to the director. Interest was charged at 2% where applicable and the loan was repayable on demand.

Transactions with the director

2023

At 1 March 2022
£

Advances to director
£

Repayments by director
£

At 28 February 2023
£

A Harris

(1,064)

35,549

(38,050)

(3,565)

         
       

 

2022

At 10 February 2021
£

Advances to director
£

Repayments by director
£

At 28 February 2022
£

A Harris

-

46,320

(47,384)

(1,064)